Tags » Bisphosphonates

Osteoporosis treatment may also benefit breast cancer patients

Treatment approaches to reduce the risk of bone complications (metastasis) associated with breast cancer may be one step closer to becoming a reality. 

According to a study led by a team at the Research Institute of the McGill University Health Centre (RI-MUHC), findings show that medication used to treat bone deterioration in post-menopausal women may also slow skeletal metastasis caused from breast cancer. 435 more words


The Role of Vitamin D Supplementation in Patients Receiving Bisphosphonates

Written by: Ross Finesmith, M.D.

Osteoporosis has become a significant public health concern over the past 10 years. As modern medicine increases our lifespan, the incidence of hip fractures related to osteoporosis increases at a disproportionally faster rate. 690 more words

Clinical/Therapeutic Area

Another Look at Bisphosphonates and Jaw Osteonecrosis

A recent study in the Journal of Clinical Endocrinology & Metabolism found that approximately one out of 200 Taiwanese who used oral alendronate long term for osteoporosis developed osteonecrosis of the jaw (ONJ). 123 more words

Surgeon Edition